Associations between the <scp>ALSFRS‐R</scp> score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of <scp>ALSFRS‐R</scp> scores in clinical studies <scp>MCI186</scp> ‐16, <scp>MCI186</scp> ‐17, and <scp>MCI186</scp> ‐19-Reference-Cited by-同舟云学术

Associations between the ALSFRS‐R score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of ALSFRS‐R scores in clinical studies MCI186 ‐16, MCI186 ‐17, and MCI186 ‐19

Published:2022-09-02 Issue:5 Volume:66 Page:593-602
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Takahashi Fumihiro¹^ORCID,Kano Osamu²,Nagano Yoshito¹,Yoneoka Takatomo¹,Nelson Sally³,Ushirogawa Yoshiteru¹

Affiliation:

1. Mitsubishi Tanabe Pharma Corporation Tokyo Japan

2. Department of Neurology Toho University, Faculty of Medicine Ota‐ku Japan

3. Mitsubishi Tanabe Pharma America, Inc Jersey City New Jersey

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27700

Reference19 articles.

1. Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: post hoc analysis of studies MCI186‐16, MCI186‐17, and MCI186‐19;Takahashi F;Muscle Nerve,2022

2. Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone

3. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

4. Low uric acid levels in serum of patients with ALS: Further evidence for oxidative stress?

5. Peroxidase Properties of Extracellular Superoxide Dismutase

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment;Neurochemical Research;2024-06-12